JSAC(SH:600389)2019-10-28 16:00Financial Performance - Operating revenue for the first nine months rose by 29.23% to CNY 3,674,299,190.00 year-on-year[18] - Net profit attributable to shareholders decreased by 2.48% to CNY 253,072,175.88 compared to the same period last year[18] - Basic earnings per share decreased by 2.63% to CNY 0.8508[20] - Revenue for the period increased by 29.23% to ¥3,674,299,190.00 from ¥2,843,140,495.19 year-over-year, mainly due to higher sales of pesticides and trade products[36] - Net profit for Q3 2019 was ¥67,846,584.83, compared to ¥76,286,940.52 in Q3 2018, reflecting a decrease of approximately 11%[66] - The company's operating profit for the first three quarters of 2019 was ¥319,879,072.70, down from ¥340,322,754.89 in the same period of 2018[73] - The total comprehensive income for Q3 2019 was ¥62,618,109.64, compared to ¥75,703,709.62 in Q3 2018, reflecting a decline of 17.3%[76] Assets and Liabilities - Total assets increased by 38.72% to CNY 4,448,257,038.45 compared to the end of the previous year[18] - Total current assets increased to approximately $2.57 billion as of September 30, 2019, up from $1.55 billion at the end of 2018, representing a growth of 65.2%[49] - Total assets reached approximately $4.45 billion, compared to $3.21 billion at the end of 2018, an increase of 38.5%[50] - Total liabilities increased to approximately $2.42 billion from $1.38 billion, representing a growth of 75.5%[50] - The company's total assets increased to ¥4,319,067,326.39 from ¥3,176,499,128.66, marking a growth of 36% year-over-year[59] - Total liabilities rose to ¥2,376,968,711.94, up 72% from ¥1,378,927,993.83 in the previous year[59] - Current liabilities amounted to ¥1,257,917,075.76, including short-term borrowings of ¥200,000,000.00 and accounts payable of ¥324,902,099.69[95] Cash Flow - Net cash flow from operating activities increased by 8.03% to CNY 178,618,670.61 year-on-year[18] - Cash inflow from operating activities for the first three quarters of 2019 was approximately ¥2.99 billion, an increase of 38.5% compared to ¥2.16 billion in the same period of 2018[81] - Cash inflow from financing activities was approximately ¥910 million in the first three quarters of 2019, an increase from ¥540 million in the same period of 2018[87] - The ending cash and cash equivalents balance for the first three quarters of 2019 was approximately ¥515.65 million, up from ¥127.70 million in the same period of 2018[89] Shareholder Information - The total number of shareholders reached 12,290 by the end of the reporting period[22] - The largest shareholder, Nantong Industrial Holding Group Co., Ltd., holds 29.30% of shares[22] - Shareholders' equity rose to approximately $1.80 billion, with retained earnings at approximately $1.18 billion[107] Research and Development - R&D expenses surged by 109.00% to ¥124,532,545.33, reflecting the company's commitment to enhancing research and development efforts[36] - Research and development expenses for Q3 2019 were ¥52,441,070.97, an increase of 67% compared to ¥31,359,192.56 in Q3 2018[63] - Research and development expenses increased to ¥52,385,093.41 in Q3 2019, up 67.1% from ¥31,359,192.56 in Q3 2018[73] Other Financial Metrics - The weighted average return on equity decreased by 2.4973 percentage points to 13.1667%[18] - The company received government subsidies amounting to CNY 7,990,908.69 during the first nine months[20] - The company reported a loss of CNY 2,379,053.69 from fair value changes of financial assets during the reporting period[20] - Cash and cash equivalents increased by 82.65% to ¥639,530,903.77 from ¥350,146,198.66 year-over-year[27] - Other payables increased by 636.24% to ¥262,656,028.21, mainly due to consolidation of a new subsidiary and outstanding payments for an equity acquisition[33]